✦ LIBER ✦

Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder—an open-label study

✍ Scribed by Dimitrios Karaiskos; Dimitra Pappa; Elias Tzavellas; Kostas Siarkos; Everina Katirtzoglou; George N. Papadimitriou; Antonios Politis

Book ID: 112095918
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 106 KB
Volume: 28
Category: Article
ISSN: 0885-6230
DOI: 10.1002/gps.3800

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Augmentation of antidepressants with bri

Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder

✍ J. Prasko; K. Adamcova; M. Brunovsky; R. Nechutna; J. Vyskocilova; L. Zavesicka 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Adjunctive atomoxetine to SSRIs or SNRIs

Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study

✍ Adel Gabriel; Claudio Violato 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 190 KB

Changes in anxiety symptoms of ADHD adul

Changes in anxiety symptoms of ADHD adult patients with co-morbid refractory generalized anxiety disorder treated with mixed amphetamine salts (ADDERALL XR): An open label study

✍ A. Gabriel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Duloxetine and care management treatment

Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study

✍ Jordan F. Karp; Debra K. Weiner; Mary A. Dew; Amy Begley; Mark D. Miller; Charle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective In older adults, major depressive disorder (MDD) and chronic low back pain (CLBP) are common and mutually exacerbating. We predicted that duloxetine pharmacotherapy and Depression and Pain Care Management (DPCM) would result in (1) significant improvement in MDD and CLBP a

Comorbidity of social phobia, generalize

Comorbidity of social phobia, generalized anxiety disorder and alcohol: An epidemiologic study in alcohol-dependent patients

✍ D. Papéta; G. Tourinel; C. Dissoubray; J.P. Boutin; J.D. Favre 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 129 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

✍ Cengiz Akkaya; Enver Yusuf Sivrioglu; Semra Akgoz; Salih Saygin Eker; Selcuk Kir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Objective: The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (mdd) and mdd with anxiety features to venlafaxine xr. ## Method: Patients with mdd, aging 18 between 65 years, were randomly allocated to two groups receiv